Journal
Blood Advances
Publication Date
7-11-2023
Volume
7
Issue
13
First Page
2983
Last Page
2993
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2022008916
Rights and Permissions
Sawalha Y, Goyal S, Switchenko JM, Romancik JT, Kamdar M, Greenwell IB, Hess BT, Isaac KM, Portell CA, Mejia Garcia A, Goldsmith S, Grover NS, Riedell PA, Karmali R, Burkart M, Buege M, Akhtar O, Torka P, Kumar A, Hill BT, Kahl BS, Cohen JB. A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma. Blood Adv. 2023 Jul 11;7(13):2983-2993. doi: 10.1182/bloodadvances.2022008916. © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Sawalha, Yazeed; Goldsmith, Scott; Kahl, Brad S; and et al., "A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma." Blood Advances. 7, 13. 2983 - 2993. (2023).
https://digitalcommons.wustl.edu/oa_4/2198
Additional Links
Supplemental material is available for this article at publisher site.
